Kuis terkait panduan · Sedang Tingkat

AI dalam Kuis Keamanan Obat dan Pharmacovigilance

Tinjau laporan kejadian buruk, deteksi sinyal, dan pengkodean standar dalam alur kerja pengawasan keamanan obat di seluruh produk.

Pertanyaan 1 dari 8

Apa tujuan utama dari farmakovigilans?

Pratinjau setiap pertanyaan8 pertanyaan

Jawaban dan penjelasan muncul saat Anda mengikuti kuis.

  1. Apa tujuan utama dari farmakovigilans?
    • Mendeteksi, menilai, dan mencegah bahaya obat setelah digunakan
    • Memasarkan obat baru ke dokter
    • Penetapan harga eceran obat
    • Merancang kemasan pil
  2. In the published n2c2 clinical NLP system, what information did the system extract from narrative notes?
    • Only patients’ handwritten signatures
    • Medication and adverse-event concepts and their relations
    • Only final regulatory decisions
    • Only medicine prices
  3. Apa yang terdeteksi oleh analisis disproporsionalitas dalam database kejadian buruk?
    • Perbedaan harga antara obat merek dan obat generik
    • Rumah sakit mana yang paling banyak menyampaikan laporan
    • Pasangan kejadian obat dilaporkan lebih sering daripada perkiraan statistik
    • Tanggal kadaluwarsa obat
  4. What is VigiBase, according to Uppsala Monitoring Centre?
    • A database of randomized clinical-trial efficacy results only
    • A list of confirmed causal side effects for every medicine
    • A commercial catalogue of approved drug prices
    • The WHO global database of reported adverse events for medicines and vaccines
  5. Untuk apa MedDRA digunakan dalam saluran farmakovigilans?
    • Kosakata medis standar untuk mengkodekan reaksi dan kondisi
    • Sebuah merek kemasan farmasi
    • Aplikasi penjadwalan untuk dokter
    • Sejenis pemindai MRI
  6. Which sequence does UMC describe in its signal-management process?
    • Diagnosis, prescription, dispensing, billing and discharge
    • Detection, validation, prioritisation, assessment and communication
    • Data collection, automatic causality decision, recall and litigation
    • Model training, deployment, billing and marketing
  7. How should a high disproportionality score in a spontaneous-report database be interpreted?
    • As a population incidence rate for all patients
    • As a confirmed causal adverse reaction
    • As a statistical signal for further assessment, not proof that the drug caused the event
    • As proof that no other factor contributed
  8. Which four elements satisfy the minimum ICSR criteria in ICH E2D(R1)?
    • A confirmed causal link, a batch number, a prescriber signature, and a laboratory result
    • A product label, a randomized trial, a treatment response, and a safety committee vote
    • A hospital admission, a known dose, a genetic profile, and a published case report
    • An adverse event or other observation, a suspect or interacting product, an identifiable patient, and an identifiable reporter